Stock Analiz

BIO-TECHNE Corp (TECH) stock forecast and price target

Price $72.80 · data as of November 13, 2026

12-month price target

Average target$70.50
Upside / downside−3.2%
Analysts10
ConsensusHold
Low $50.00Average $70.50High $73.00

Gold marker: average target · white marker: today’s price ($72.80)

Analyst ratings

Strong buy 0Buy 0Hold 12Sell 1Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends June 30, 2027
$2.03+5.2%$1.3B
Next fiscal year
ends June 30, 2028
$2.31+13.8%$1.4B
Next quarter
ends December 31, 2026
$0.47+2.1%$308M
Quarter after
ends March 31, 2027
$0.55+3.9%$327M

Consensus of the analysts covering BIO-TECHNE, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 3.2% downside over 12 months. Our discounted cash flow model with moderate assumptions puts BIO-TECHNE’s intrinsic value about 60% below today’s market value, and it scores 2.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the BIO-TECHNE stock price target?

The average 12-month target from 10 analysts is $70.50, 3.2% below the current price of $72.80 Targets range from $50.00 to $73.00.

Is BIO-TECHNE a buy according to analysts?

The consensus rating is “Hold” (12 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is BIO-TECHNE expected to earn?

Analysts expect EPS of $2.03 for the fiscal year ending June 30, 2027 and $2.31 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.